<?xml version="1.0" encoding="UTF-8"?>
<ref id="B38-marinedrugs-17-00139" class="ref">
 <label class="label">38.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Aissaoui</surname>
    <given-names class="given-names">N.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Abidi</surname>
    <given-names class="given-names">F.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Hardouin</surname>
    <given-names class="given-names">J.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Abdelkafi</surname>
    <given-names class="given-names">Z.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Marrakchi</surname>
    <given-names class="given-names">N.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Jouenne</surname>
    <given-names class="given-names">T.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Marzouki</surname>
    <given-names class="given-names">M.N.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">Two novel peptides with angiotensin I converting enzyme inhibitory and antioxidative activities from 
   <italic class="italic">Scorpaena notata</italic> muscle protein hydrolysate
  </article-title>
  <source class="source">Biotech. Appl. Biochem.</source>
  <year class="year">2017</year>
  <volume class="volume">64</volume>
  <fpage class="fpage">201</fpage>
  <lpage class="lpage">210</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1002/bab.1478</pub-id>
  <?supplied-pmid 26799603?>
  <pub-id pub-id-type="pmid" class="pub-id">26799603</pub-id>
 </element-citation>
</ref>
